This week's NDEWS Hotspot Alerts report includes 32 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
Reports
The Model Recovery Ready Workplaces Act establishes a program by which employers can become recovery-ready participants or certified as...
This week's NDEWS Hotspot Alerts report includes 21 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
The DEA Toxicology Testing Program (DEA TOX) published its Second Quarter 2023 Report presenting results of cases analyzed and...
This week's NDEWS Hotspot Alerts report includes 32 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
LAPPA recently published a fact sheet in its Novel Psychoactive Substances series - Bromazolam. “Novel” substances are not never-before-seen...
The Drug Enforcement Administration (DEA), US Customs and Border Protection (CBP), and US Food and Drug Administration (FDA)––working collaboratively...
The Rapid Street Reporting (RSR) team visited Phoenix, AZ on September 22–24, 2023 and surveyed 363 individuals. After alcohol...
Across our nation, communities are suffering the scourge of an illicit synthetic opioid epidemic that is challenging law enforcement,...
Federal Register: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
Lisa McElhaney / /The DEA temporarily placed two benzimidazole-opioids––N-desethyl isotonitazene and N-piperidinyl etonitazene––in Schedule I of the Controlled Substances Act.
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024